返回 Agenda
Global Perspective on ICH: Part 2 of 2
Session Chair(s)
Patrick Brady, PHARMD
Global Head, Therapeutic Innovation & Regulatory Science
IQVIA, United States
This forum will provide an overview of the ICH association and offer insight into strategic, long-term views on advancing global convergence of regulatory science through ICH, including important enablers such as stakeholder partnerships and greater connection to other harmonization initiatives. A panel of experts will discuss the benefits of ICH and global regulatory harmonization, including views on key strategic topics that will enhance simultaneous global drug development.
Learning Objective : Discuss what the ICH reforms mean for global development as ICH moves toward being a truly global platform for international harmonization; Describe ICH's connection to other global harmonization/convergence forums; Identify the value and benefits of global regulatory harmonization and the ICH; Discuss opportunities to advance regulatory science through ICH.
Speaker(s)
Fostering Simultaneous Global Development via Regulatory Harmonization and ICH Reforms
Camille Jackson
Flatiron Health , United States
Director, Regulatory Policy; Legal and Regulatory
Partnership and Global Connectivity After ICH's Reform: New Opportunities for Global Regulatory Harmonization and Advancing Regulatory Science
Jerry Stewart, JD, MSC, RPH
Pfizer Inc, United States
Vice President Global Regulatory Policy and Intelligence, Global RA
Panelist
Lawrence Liberti, PHD, RAC
The Kim Center/ USC DRQS, United States
Director, D.K. Kim International Center for Regulatory Science